GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (OTCPK:HUMDF) » Definitions » Gross Profit

HUMDF (Hua Medicine) Gross Profit : $5.65 Mil (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine Gross Profit?

Hua Medicine's gross profit for the six months ended in Jun. 2024 was $6.58 Mil. Hua Medicine's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was $5.65 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Hua Medicine's gross profit for the six months ended in Jun. 2024 was $6.58 Mil. Hua Medicine's Revenue for the six months ended in Jun. 2024 was $14.15 Mil. Therefore, Hua Medicine's Gross Margin % for the quarter that ended in Jun. 2024 was 46.53%.

Hua Medicine had a gross margin of 46.53% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 8 years, the highest Gross Margin % of Hua Medicine was 48.79%. The lowest was 37.58%. And the median was 46.24%.


Hua Medicine Gross Profit Historical Data

The historical data trend for Hua Medicine's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hua Medicine Gross Profit Chart

Hua Medicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial - - - 1.10 5.23

Hua Medicine Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.10 6.15 -0.94 6.58

Competitive Comparison of Hua Medicine's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Hua Medicine's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hua Medicine's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hua Medicine's Gross Profit distribution charts can be found below:

* The bar in red indicates where Hua Medicine's Gross Profit falls into.



Hua Medicine Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Hua Medicine's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=10.729 - 5.495
=5.23

Hua Medicine's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=14.151 - 7.567
=6.58

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $5.65 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Hua Medicine's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=6.58 / 14.151
=46.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Hua Medicine  (OTCPK:HUMDF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Hua Medicine had a gross margin of 46.53% for the quarter that ended in Jun. 2024 => Durable competitive advantage


Hua Medicine Gross Profit Related Terms

Thank you for viewing the detailed overview of Hua Medicine's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Hua Medicine Business Description

Traded in Other Exchanges
Address
Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.

Hua Medicine Headlines